You searched for "retinopathy"
Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network
1 February 2017
| Nick Astbury, Philip Burgess, Allen Foster (Prof), Denise Mabey, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...
Diabetic retinopathy and body fat distribution and adipokine secretion in type 2 diabetics
The major risk factors for diabetic retinopathy (DR) in patients with diabetes are poor glycaemic or blood pressure control, duration of diabetes and nephropathy related to the severity of DR. Several studies suggest that DR is associated with visceral fat...
Comparison between findings in OCTA and FA in patients with diabetic retinopathy
1 April 2020
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this study the authors present a prospective cross-sectional comparative study of typical findings of diabetic retinopathy to analyse the agreement between the image modalities of optical coherence tomography angiography (OCTA) and fluorescein angiography (FA). Fifty-three eyes of 42 patients...
Smartphone ophthalmoscopy vs. slit-lamp biomicroscopy in diabetic retinopathy
1 June 2016
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
In this prospective, comparative, clinical study the authors’ aim was to assess the reliability and accuracy of smartphone ophthalmoscopy as compared with standard slit-lamp biomicroscopy in the grading of diabetic retinopathy. One hundred and twenty consecutive, new, diabetic patients underwent...
Association between neurodegeneration and macular perfusion in the progression of diabetic retinopathy
9 August 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Diabetes, Neurodegeneration, Progression, Retinopathy, Vessel closure
In this prospective three-year longitudinal study, the authors aimed to explore the relation between retinal neurodegenerative changes and vessel closure (VC) in individuals with non-proliferative diabetic retinopathy (NPDR). The participants included 74 individuals with type 2 diabetes, NPDR, and Early...
Capacity-strengthening for diabetic retinopathy services in low- and middle-income countries
3 February 2023
| Covadonga Bascaran, Clare Waite, Darra Burt, Andi Suryanita Tajuddin, Marcia Zondervan
|
EYE - General
Introduction DR-NET eye health professionals in low- and middle-income countries (LMICs) have, since 2015, been able to access training in diabetic retinopathy (DR) grading provided by Gloucestershire Retinal Education Group (GREG). GREG, led by Professor Peter Scanlon and based at...
Do steroids prevent progression to proliferative diabetic retinopathy (PDR)?
1 February 2017
| Usha Chakravarthy (Prof)
|
EYE - Vitreo-Retinal
There is continuing debate on the merits of pan-retinal photocoagulation (PRP) for severe pre-proliferative and proliferative DR versus the newer therapies that inhibit vascular endothelial growth factor (VEGF). This has been hotly debated [1] following the publication of findings from...
Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?
1 October 2017
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...
Retinopathy of prematurity treatment in the South West of England: long-term outcomes 1997-2008
1 December 2014
| Anna Pang, Jonathan Park, Anthony Quinn, Roland Ling
|
EYE - Vitreo-Retinal
Retinopathy of prematurity (ROP) is a condition that affects the developing retinal vascular system of pre-term babies. If left untreated, ROP can lead to severe visual impairment. The severe visual impairment caused by untreated ROP can be prevented by screening...
Assessing failure of laser coagulation treatment for type 1 retinopathy of prematurity
7 April 2021
| Kareem Waleed Alsaffarini
|
EYE - Vitreo-Retinal
The authors present the findings of a retrospective study to examine the cause of treatment failures in type 1 retinopathy of prematurity (ROP). They reviewed the medical charts of all infants with persistent disease post laser treatment at Uppsala University...
DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity (TR-ROP)
This article examines the efficacy of using the DIGIROP online prediction model in estimating the risk of retinopathy of prematurity (ROP) requiring treatment in two Portuguese hospitals. Portuguese screening criteria for ROP mirrors that of the UK (<32 weeks gestation...
What factors influence attendance at retinopathy of prematurity screening follow-up?
4 August 2025
| Lauren R Hepworth
|
EYE - Paediatrics
The authors present a retrospective medical notes review of babies attending outpatient appointments for retinopathy of prematurity (ROP) examination, over a 12-month period. The aim of the study was to assess compliance with these appointments at a single centre. Data...
